Evidence map›Paper›PMID 23874858›Full record

ArticlePloS one2013

SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.

Himangi G Marathe, Gaurav Mehta, Xiaolu Zhang, Ila Datar, Aanchal Mehrotra, Kam C Yeung, Ivana L de la Serna

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Novel Role for Oligodendrocyte Precursor Cells (OPCs) and Sox10 in Mediating Cellular and Behavioral Responses to Heroin.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Brg1-dependent chromatin remodelling is not essentially required during oligodendroglial differentiation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  16. Article
  17. The role of BAF (mSWI/SNF) complexes in mammalian neural development.American journal of medical genetics. Part C, Seminars in medical genetics · 2014
    Article
  18. SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma.Critical reviews in eukaryotic gene expression · 2014
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Himangi G MaratheDepartment of Biochemistry and Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.
Gaurav Mehta
Xiaolu Zhang
Ila Datar
Aanchal Mehrotra
Kam C Yeung
Ivana L de la Serna
University of Toledo · US

Funding

Regulation of Melanocyte Differentiation by SWI/SNF Chromatin Remodeling EnzymesR01AR059379 · NIAMS · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI DE LA SERNA, IVANA L · 2010 to 2014
$1.6M
NIAMS NIH HHS R01 AR059379PHS HHS R01 ARO5937
6 · The paper itself

Abstract

SOX10 is a Sry-related high mobility (HMG)-box transcriptional regulator that promotes differentiation of neural crest precursors into Schwann cells, oligodendrocytes, and melanocytes. Myelin, formed by Schwann cells in the peripheral nervous system, is essential for propagation of nerve impulses. SWI/SNF complexes are ATP dependent chromatin remodeling enzymes that are critical for cellular differentiation. It was recently demonstrated that the BRG1 subunit of SWI/SNF complexes activates SOX10 expression and also interacts with SOX10 to activate expression of OCT6 and KROX20, two transcriptional regulators of Schwann cell differentiation. To determine the requirement for SWI/SNF enzymes in the regulation of genes that encode components of myelin, which are downstream of these transcriptional regulators, we introduced SOX10 into fibroblasts that inducibly express dominant negative versions of the SWI/SNF ATPases, BRM or BRG1. Dominant negative BRM and BRG1 have mutations in the ATP binding site and inhibit gene activation events that require SWI/SNF function. Ectopic expression of SOX10 in cells derived from NIH 3T3 fibroblasts led to the activation of the endogenous Schwann cell specific gene, myelin protein zero (MPZ) and the gene that encodes myelin basic protein (MBP). Thus, SOX10 reprogrammed these cells into myelin gene expressing cells. Ectopic expression of KROX20 was not sufficient for activation of these myelin genes. However, KROX20 together with SOX10 synergistically activated MPZ and MBP expression. Dominant negative BRM and BRG1 abrogated SOX10 mediated activation of MPZ and MBP and synergistic activation of these genes by SOX10 and KROX20. SOX10 was required to recruit BRG1 to the MPZ locus. Similarly, in immortalized Schwann cells, BRG1 recruitment to SOX10 binding sites at the MPZ locus was dependent on SOX10 and expression of dominant negative BRG1 inhibited expression of MPZ and MBP in these cells. Thus, SWI/SNF enzymes cooperate with SOX10 to directly activate genes that encode components of peripheral myelin.

Indexed as

AnimalsCell LineChromatin ImmunoprecipitationChromosomal Proteins, Non-HistoneDNA HelicasesEarly Growth Response Protein 2Flow CytometryImmunoblottingMiceMyelin SheathNuclear ProteinsProtein BindingReal-Time Polymerase Chain ReactionSOXE Transcription FactorsTranscription FactorsChromosomal Proteins, Non-HistoneDNA HelicasesEarly Growth Response Protein 2Nuclear ProteinsSmarca4 protein, mouseSox10 protein, mouseSOXE Transcription FactorsSWI-SNF-B chromatin-remodeling complexTranscription Factors

Identifiers

PMID23874858
PMCPMC3712992
OpenAlexW2047660365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.